BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15816564)

  • 1. Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells.
    Waleh NS; Chao WR; Bensari A; Zaveri NT
    Anticancer Res; 2005; 25(1A):397-402. PubMed ID: 15816564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
    Park JS; Kim MH; Chang HJ; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
    Int J Oncol; 2006 Nov; 29(5):1247-52. PubMed ID: 17016658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
    Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
    Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
    Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate].
    Jiao ZQ; Lü XZ; Guo YC; Kan B; Xu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep; 41(5):380-6. PubMed ID: 18206010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.
    Kazi A; Wang Z; Kumar N; Falsetti SC; Chan TH; Dou QP
    Anticancer Res; 2004; 24(2B):943-54. PubMed ID: 15161048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs.
    Landis-Piwowar KR; Kuhn DJ; Wan SB; Chen D; Chan TH; Dou QP
    Int J Mol Med; 2005 Apr; 15(4):735-42. PubMed ID: 15754040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
    Lin SK; Shun CT; Kok SH; Wang CC; Hsiao TY; Liu CM
    Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):522-7. PubMed ID: 18490575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
    Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
    Laschke MW; Schwender C; Scheuer C; Vollmar B; Menger MD
    Hum Reprod; 2008 Oct; 23(10):2308-18. PubMed ID: 18603648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
    Lambert JD; Sang S; Hong J; Kwon SJ; Lee MJ; Ho CT; Yang CS
    Drug Metab Dispos; 2006 Dec; 34(12):2111-6. PubMed ID: 16997910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
    Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
    Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
    Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells.
    Kim SJ; Jeong HJ; Lee KM; Myung NY; An NH; Yang WM; Park SK; Lee HJ; Hong SH; Kim HM; Um JY
    J Nutr Biochem; 2007 Sep; 18(9):587-96. PubMed ID: 17446059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.
    Berger SJ; Gupta S; Belfi CA; Gosky DM; Mukhtar H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):101-5. PubMed ID: 11594758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.